Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease

Lalitha N. Guthikonda, Kelly E. Lyons, Rajesh Pahwa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Evaluation of: Olanow CW, Kieburtz K, Odin P et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 13(2), 141-149 (2014). Levodopa-induced motor complications, including motor fluctuations and dyskinesia, can be a major source of disability for Parkinson's disease patients. The development of levodopa-induced motor complications has been attributed to the pulsatile dopaminergic stimulation characteristic of conventional oral levodopa regimens. This is a review of a 12-week, randomized, controlled, double-blind, double-dummy study of continuous jejunal infusion of levodopa-carbidopa intestinal gel to determine if the continuous infusion of levodopa reduces motor complications in Parkinson's disease. Results demonstrated that levodopa-carbidopa intestinal gel significantly reduced off-time without increasing troublesome dyskinesia compared with standard oral levodopa therapy. Adverse effects were common in both the levodopa-carbidopa intestinal gel and placebo groups and were related primarily to the infusion hardware.

Original languageEnglish (US)
Pages (from-to)331-333
Number of pages3
JournalJournal of Comparative Effectiveness Research
Volume3
Issue number4
DOIs
StatePublished - Jul 1 2014

Fingerprint

Levodopa
Parkinson Disease
Gels
Dyskinesias
Double-Blind Method
Placebos
levodopa drug combination carbidopa

Keywords

  • continuous drug infusion
  • dyskinesia
  • LCIG
  • levodopa-carbidopa intestinal gel
  • motor fluctuations
  • Parkinson's disease

ASJC Scopus subject areas

  • Health Policy

Cite this

Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease. / Guthikonda, Lalitha N.; Lyons, Kelly E.; Pahwa, Rajesh.

In: Journal of Comparative Effectiveness Research, Vol. 3, No. 4, 01.07.2014, p. 331-333.

Research output: Contribution to journalArticle

Guthikonda, Lalitha N. ; Lyons, Kelly E. ; Pahwa, Rajesh. / Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease. In: Journal of Comparative Effectiveness Research. 2014 ; Vol. 3, No. 4. pp. 331-333.
@article{0027ad8b9aac4a00bd28c790c220b55d,
title = "Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease",
abstract = "Evaluation of: Olanow CW, Kieburtz K, Odin P et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 13(2), 141-149 (2014). Levodopa-induced motor complications, including motor fluctuations and dyskinesia, can be a major source of disability for Parkinson's disease patients. The development of levodopa-induced motor complications has been attributed to the pulsatile dopaminergic stimulation characteristic of conventional oral levodopa regimens. This is a review of a 12-week, randomized, controlled, double-blind, double-dummy study of continuous jejunal infusion of levodopa-carbidopa intestinal gel to determine if the continuous infusion of levodopa reduces motor complications in Parkinson's disease. Results demonstrated that levodopa-carbidopa intestinal gel significantly reduced off-time without increasing troublesome dyskinesia compared with standard oral levodopa therapy. Adverse effects were common in both the levodopa-carbidopa intestinal gel and placebo groups and were related primarily to the infusion hardware.",
keywords = "continuous drug infusion, dyskinesia, LCIG, levodopa-carbidopa intestinal gel, motor fluctuations, Parkinson's disease",
author = "Guthikonda, {Lalitha N.} and Lyons, {Kelly E.} and Rajesh Pahwa",
year = "2014",
month = "7",
day = "1",
doi = "10.2217/cer.14.33",
language = "English (US)",
volume = "3",
pages = "331--333",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6305",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease

AU - Guthikonda, Lalitha N.

AU - Lyons, Kelly E.

AU - Pahwa, Rajesh

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Evaluation of: Olanow CW, Kieburtz K, Odin P et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 13(2), 141-149 (2014). Levodopa-induced motor complications, including motor fluctuations and dyskinesia, can be a major source of disability for Parkinson's disease patients. The development of levodopa-induced motor complications has been attributed to the pulsatile dopaminergic stimulation characteristic of conventional oral levodopa regimens. This is a review of a 12-week, randomized, controlled, double-blind, double-dummy study of continuous jejunal infusion of levodopa-carbidopa intestinal gel to determine if the continuous infusion of levodopa reduces motor complications in Parkinson's disease. Results demonstrated that levodopa-carbidopa intestinal gel significantly reduced off-time without increasing troublesome dyskinesia compared with standard oral levodopa therapy. Adverse effects were common in both the levodopa-carbidopa intestinal gel and placebo groups and were related primarily to the infusion hardware.

AB - Evaluation of: Olanow CW, Kieburtz K, Odin P et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 13(2), 141-149 (2014). Levodopa-induced motor complications, including motor fluctuations and dyskinesia, can be a major source of disability for Parkinson's disease patients. The development of levodopa-induced motor complications has been attributed to the pulsatile dopaminergic stimulation characteristic of conventional oral levodopa regimens. This is a review of a 12-week, randomized, controlled, double-blind, double-dummy study of continuous jejunal infusion of levodopa-carbidopa intestinal gel to determine if the continuous infusion of levodopa reduces motor complications in Parkinson's disease. Results demonstrated that levodopa-carbidopa intestinal gel significantly reduced off-time without increasing troublesome dyskinesia compared with standard oral levodopa therapy. Adverse effects were common in both the levodopa-carbidopa intestinal gel and placebo groups and were related primarily to the infusion hardware.

KW - continuous drug infusion

KW - dyskinesia

KW - LCIG

KW - levodopa-carbidopa intestinal gel

KW - motor fluctuations

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84907859002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907859002&partnerID=8YFLogxK

U2 - 10.2217/cer.14.33

DO - 10.2217/cer.14.33

M3 - Article

VL - 3

SP - 331

EP - 333

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6305

IS - 4

ER -